$0.1550
At close: Apr 14, 2:04 PM EDT
Comments
Loading...
Hofseth BioCare Analyst Ratings and Price Targets | OTC:HOFBF | Benzinga
Hofseth BioCare Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Hofseth BioCare Corp from these most-recent analyst ratings.
Analyst Ratings for Hofseth BioCare
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Hofseth BioCare (HOFBF) stock?
There is no price target for Hofseth BioCare
What is the most recent analyst rating for Hofseth BioCare (HOFBF)?
There is no analyst for Hofseth BioCare
When was the last upgrade for Hofseth BioCare (HOFBF)?
There is no last upgrade for Hofseth BioCare
When was the last downgrade for Hofseth BioCare (HOFBF)?
There is no last downgrade for Hofseth BioCare.
When is the next analyst rating going to be posted or updated for Hofseth BioCare (HOFBF)?
There is no next analyst rating for Hofseth BioCare.
Is the Analyst Rating Hofseth BioCare (HOFBF) correct?
There is no next analyst rating for Hofseth BioCare.
Browse analyst ratings and price targets on all stocks.
